Bronchitis Antibacterial Medicine Section
bronchitis is a common respiratory disease that can be classified as acute and chronic. When bronchitis is caused by, or accompanied by, bacterial infections, the rational use of antibacterial drugs becomes a key part of the treatment. This will provide you with detailed information on the treatment of antibacterial drugs for general bronchitis.
Bacteria infection factor for bronchitis
In acute bronchitis, bacterial infections are often followed by viral infections, and common pathogenic bacteria include pneumococcus, haemophilus influenzae, etc. Chronic bronchitis, on the other hand, during acute onset, is often exacerbated by bacterial infections, such as the Cartagena fungi, which are also common pathogens. Knowledge of these pathogenic bacteria facilitates the targeting of antibacterial drugs.
Time for antibacterial treatment.
Not all bronchitis requires antibacterial drugs. For acute bronchitis, if caused solely by the virus, it is usually self-restrictive and does not require antibacterial treatment. However, the use of antibacterial drugs needs to be considered when patients experience symptoms of bacterial infections, such as coughing, fever and white cell rise. For chronic bronchitis stabilization periods, antibacterial treatment is generally not required, while antibacterial drugs should be given in a timely manner when acute symptoms, such as cough, cough, asthma, etc., are aggravated and the amount of scintillation increases.
Types of antibacterial drugs commonly used
1. Beta – intraamide
Including penicillin and headbactrin. Penicillin, for example, Amosilin, has a good antibacterial activity for pneumococcus, etc. There are two generations, two generations, three generations, and so on. A generation of bacterium cystasy, such as thalamus, has a relatively good antibacterial effect on gland positives; a second generation of bacterium, such as thiram, is effective for both gland positives and part of the gland cacterium; and a third generation of bacterium, such as thiram, has a wider spectrum of antibacterial strains and stronger antibacterial activity and can be used for the treatment of infections such as haemophilus influenzae. The mechanism for the use of such drugs is mainly to inhibit the synthesis of bacterial cell walls.
2. Large ring esters
Like Archicin, roacin. They have better antibacterial effects on atypical pathogens, such as pneumonia, chlamydia, and have some effect on part of the gland positive. The mechanism of action is antibacterial by inhibiting the synthesis of bacterial proteins. Such drugs may be used when persons with bronchitis suspect that atypical pathogens are infected.
3. Xenone
Common oxyfluorosalts, left oxysalts, etc. Such drugs have a broad spectrum of antibacterial resistance, with a high level of antibacterial activity for the gebrane and the geland positive, and are effective for common bronchial bacteria such as pneumococcus and haemophilus influenzae. At the same time, it also has effects on atypical pathogens, such as chlamydia and chlamydia. Its antibacterial mechanism is the inhibition of the bacteria’ DNA rotation enzymes, which hinders the replication of bacteria’ DNA.
Principles for the selection of antibacterial drugs
1. By pathogen type
If it is specifically a case of pneumocococcal infection, it is possible to choose penicillin or a herbicide; if it is a haemophilus influenzae infection, it is possible to choose a hemorrhagic enzymes or thorogenesis; and for patients suspected of chlamydia or chlamydia infection, a large rimone or thorogenone is the appropriate option.
2. Consideration of patient factors
In the case of children, the use of quinone should be avoided, as it may affect the child ‘ s bone development. In the case of older persons or patients with incomplete liver and kidneys, care is taken to adjust the dose of the drug in the choice of antibacterial drugs and to avoid adverse reactions due to the accumulation of drugs. For example, care should be taken in the use of amino-sugar-type drugs because of their kidney and ear toxicity.
3. The adverse effects of drugs
Each antibacterial drug has its specific adverse effects. In the case of beta-nimide, which may cause allergies, the patient ‘ s history of allergies before use; in the case of large cyclic esters, which may cause gastrointestinal reactions such as nausea, vomiting, etc.; and in the case of quinone, which may cause adverse reactions to the central nervous system such as dizziness, insomnia, etc. When choosing a drug, it is important to weigh the advantages and disadvantages and to select, to the extent possible, a drug with a low level of adverse effect.
Treatment of antibacterials
For acute bronchitis, anti-bacterial treatment is generally 5-7 days. If the condition is serious or there are complications, the treatment may be extended as appropriate. Chronic bronchitis occurs acutely and the course is generally 7 – 10 days. It should be noted, however, that there should be no premature cut-off, so that bacteria are not completely eliminated, which leads to repeated cases, and antibacterial drugs cannot be used for long periods of time, so as not to cause problems such as geriatric disorders.
Attention to antibacterial treatment
In the treatment of bronchitis with anti-bacterial drugs, the patient is required to take the medication on time and in accordance with medical instructions. It is not possible to reduce or reduce the dose. At the same time, care should be taken in the treatment to observe signs of change, and if the symptoms persist or are aggravated, timely medical treatment should be provided. In addition, it is important to take care of the rest and drink more water, which will help in the discharge and recovery of the sap.
In summary, bronchial antibacterial treatment requires a combination of multiple factors and a rational selection and use of antibacterial drugs to improve treatment effectiveness and reduce the incidence of adverse reactions and bacterial resistance.
